SUBSTITUIERTE PHENETHYLAMINE MIT SEROTONINERGISCHER UND/ODER NOREPINEPHRINERGISCHER AKTIVITÄT

European patent · EP1954669 · Deleted

Register entry

Publication number
EP1954669
Application number
EP06844628
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Nov 30, 2006
Published
Aug 13, 2008
Granted
Jul 8, 2015
Deleted
Jun 23, 2023
Reason
Annual fee unpaid
IPC classes
C07C 217/74 (2006.01)
A61K 31/135 (2006.01)
A61P 25/00 (2006.01)
Priority
US 741315 P 01.12.2005
US 841366 P 30.08.2006
PCT application
PCT/US2006/045673 30.11.2006
PCT publication
WO2007/064697 07.06.2007
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 23, 2023

    Deleted, fee unpaid

    Published in Swissreg on 23.06.2023

  2. Jan 7, 2022

    Transferred

    Owner
    Auspex Pharmaceuticals, Inc., 1261 Liberty One Way, Suite C, Vista, CA 92081-8356, USA → Acadia Pharmaceuticals Inc., 12830 El Camino Real, Suite 400, San Diego, CA 92130, USA

    Published in Swissreg on 07.01.2022

  3. Jul 8, 2015

    Granted

    Published in Swissreg on 08.07.2015

Parties

Holder

Acadia Pharmaceuticals Inc.

12830 El Camino Real, Suite 400, San Diego, CA 92130, US

Inventor

GANT, Thomas G.

Carlsbad, California 92009, US

SARSHAR, Sepehr

Cardiff By The Sea, California 92007, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.